Crispr Therapeutics shares owned by Levin Capital Strategies
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Levin Capital Strategies
from 13F filings
Historical chart of Levin Capital Strategies investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Levin Capital Strategies
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $514k | 11k | 46.98 |
2024-06-30 | $375k | 6.9k | 54.01 |